In a separate study, using the EZH2 PROTAC-degrader MS1973, EZH2 degradation was necessary and more effective than enzymatic inhibition in eliminating relapse-initiating cells in a retinoic acid-dependent model of acute promyelocytic leukemia (63). The gene discussed is EZH2; the disease is acute promyelocytic leukemia.